24.1.1
Definitions
Clinical HIV Guidelines, 5th Edition, 2022. Chapter 24, Pharmacovigilance.
Clinical description
Adverse Event (AE)
- Any untoward medical occurrence in a patient. It does not necessarily have a causal relationship
with any medicine administered.
Adverse drug reaction (ADR)
- An unintended noxious response to a medicinal product
Suspected adverse drug reaction
- May present as a new sign, symptom, abnormal laboratory finding or specific disease
- Suspected, but not confirmed to be caused by any medicine administered. Common causes of AEs
include advancement/complication of the underlying disease, manifestation of a new disease, or indeed the medicine administered.
- Healthcare workers must report all suspected ADRs to the National Pharmacovigilance Centre at
Pharmacy and Medicines Regulatory Authority (PMRA)
Side effect (SE)
- An unintended effect of a medicinal product occurring at doses normally used in humans, which is
related to its pharmacological properties.
- All ADRs are AEs, but not all AEs are ADRs. All AEs and ADRs are harmful, but SEs can be either
harmful or beneficial.
Pharmacovigilance 117 Safety signal
- An ADR which was previously either unknown or poorly documented in terms of its distribution,
severity, incidence or clinical presentation.
- It is not possible, especially at bed side, to determine whether an individual case constitutes a
safety signal.
- Pharmacovigilance aims to detect safety signals for period evaluation of the benefit-risk balance
of the medicine.
Check doses against the printed guideline and your clinical judgement before treating a patient. Spotted an error? Report it from the contact links below.
Need this without data?
The app holds every guideline on your device, with calculators, bookmarks and notes.